We are live on
!
Find out more
DA
Dillon & Associates Portfolio holdings
AUM
$726M
1-Year Est. Return
18.59%
This Fund
S&P 500
This Quarter
Est. Return
+2.72%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$522M
AUM Growth
+$11.4M
(+2.2%)
Cap. Flow
+$1.47M
Cap. Flow
% of AUM
0.28%
Top 10 Holdings %
Top 10 Hldgs %
50.26%
Holding
72
New
1
Increased
37
Reduced
25
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$927K |
| 2 |
Amazon
AMZN
|
+$504K |
| 3 |
Norfolk Southern
NSC
|
+$492K |
| 4 |
Canadian National Railway
CNI
|
+$401K |
| 5 |
NVIDIA
NVDA
|
+$366K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Paychex
PAYX
|
+$1.2M |
| 2 |
Apple
AAPL
|
+$854K |
| 3 |
Merck
MRK
|
+$364K |
| 4 |
Becton Dickinson
BDX
|
+$353K |
| 5 |
Stryker
SYK
|
+$341K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.59% |
| 2 | Healthcare | 18.89% |
| 3 | Communication Services | 13.26% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Financials | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Amgen
AMGN
$208B
| $597K | 0.11% |
2,804
-30
| -1% | -$6.91K |
|
52
Eaton
ETN
$161B
| $559K | 0.11% |
3,751
+108
| +3% | +$17.3K |
|
|
K
53
DELISTED
Kellanova
K
| $539K | 0.1% |
8,967
-41
| -0.5% | -$2.46K |
|
54
Chipotle Mexican Grill
CMG
$47.2B
| $533K | 0.1% |
14,650
+100
| +0.7% | +$3.64K |
|
|
55
Merck
MRK
$322B
| $530K | 0.1% |
7,071
-4,792
| -40% | -$364K |
|
56
UnitedHealth
UNH
$376B
| $447K | 0.09% |
1,144
| – | – |
|
57
NeoGenomics
NEO
$1.96B
| $384K | 0.07% |
8,000
| – | – |
|
58
Emerson Electric
EMR
$83.9B
| $367K | 0.07% |
3,907
+25
| +0.6% | +$2.49K |
|
59
Cisco
CSCO
$457B
| $333K | 0.06% |
6,160
-1,595
| -21% | -$89.5K |
|
60
Generac Holdings
GNRC
$11.6B
| $313K | 0.06% |
765
+68
| +10% | +$29.1K |
|
|
61
Becton Dickinson
BDX
$45.6B
| $301K | 0.06% |
1,253
-1,438
| -53% | -$353K |
|
62
Capital One
COF
$128B
| $267K | 0.05% |
1,650
| – | – |
|
63
Bristol-Myers Squibb
BMY
$133B
| $261K | 0.05% |
4,418
-9
| -0.2% | -$593 |
|
64
Coca-Cola
KO
$377B
| $252K | 0.05% |
4,842
-199
| -4% | -$11.1K |
|
|
WBA
65
DELISTED
Walgreens Boots Alliance
WBA
| $247K | 0.05% |
5,248
-59
| -1% | -$2.85K |
|
66
United Parcel Service
UPS
$88.6B
| $235K | 0.05% |
1,293
-27
| -2% | -$5.33K |
|
|
MRSH
67
Marsh
MRSH
$90.5B
| $234K | 0.04% |
1,548
+20
| +1% | +$3.02K |
|
68
US Bancorp
USB
$98.2B
| $229K | 0.04% |
3,877
+34
| +0.9% | +$1.94K |
|
69
Huntington Bancshares
HBAN
$34.4B
| $227K | 0.04% |
15,139
| – | – |
|
70
Align Technology
ALGN
$12.1B
| $213K | 0.04% |
+320
| New | +$217K |
|
71
Imunon
IMNN
$6.68M
| $21K | ﹤0.01% |
114
| – | – |
|
72
Rockwell Medical
RMTI
$28.4M
| $7K | ﹤0.01% |
104
| – | – |
|
Similar funds
TC
F
SDH
SCM
MWP
FAN
TFHU
AGAM
Dillon & Associates's Q3 2021 Portfolio in Review
As of Q3 2021, Dillon & Associates held 72 positions worth $522M, up 2.2% from $511M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 1.4%. Dillon & Associates opened 1 new position and made no exits, leaving the 72-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Communication Services.
- Dillon & Associates's largest Q3 2021 buy was Align Technology: 320 shares worth $213K.
- Dillon & Associates added most to Regeneron Pharmaceuticals in Q3 2021, an estimated $927K increase.
- Dillon & Associates's biggest Q3 2021 reduction was Paychex, cutting an estimated $1.2M.
- Dillon & Associates's ten largest holdings make up 50% of its $522M portfolio in Q3 2021.
- Dillon & Associates opened 1 new position and closed 0 in Q3 2021.
- Dillon & Associates's portfolio value rose 2.2% quarter-over-quarter to $522M.
Based on Dillon & Associates's 13F filing for Q3 2021, filed 28 Oct 2021.